Andrei Iagaru
Stanford University
H-index: 53
North America-United States
Top articles of Andrei Iagaru
Expert perspectives on controversies in castration-sensitive prostate cancer management: narrative review and report of the first US prostate cancer conference part 1
2024/4/1
Himisha Beltran
H-Index: 53
Daniel E Spratt
H-Index: 44
Andrei Iagaru
H-Index: 32
Oliver Sartor
H-Index: 56
Tian Zhang
H-Index: 1
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2
2024/4/1
Himisha Beltran
H-Index: 53
Daniel E Spratt
H-Index: 44
Andrei Iagaru
H-Index: 32
Oliver Sartor
H-Index: 56
Tian Zhang
H-Index: 1
Spatial transcriptomic analysis identifies pancreatic cancer cell surface markers for imaging and therapy
Cancer Research
2024/3/22
Guiding principles on the education and practice of theranostics
European Journal of Nuclear Medicine and Molecular Imaging
2024/3/8
Andrei Iagaru
H-Index: 32
Anita Brink
H-Index: 4
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET
2024/3/2
Andrei Iagaru
H-Index: 32
Implementation of Precision Oncology into the Diagnostic and Therapeutic Armamentarium: Actionable Takeaways from the 2023 Precision Oncology Summit
International Journal of Cancer Care and Delivery
2024/2/28
Andrei Iagaru
H-Index: 32
68Ga-RM2 PET–MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trial
The Lancet Oncology
2024/2/26
Heying Duan
H-Index: 10
Farshad Moradi
H-Index: 15
Hong Song
H-Index: 17
Shreyas Vasanawala
H-Index: 38
Andrei Iagaru
H-Index: 32
Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review
2024/2/11
Priyanka Jha
H-Index: 0
Andrei Iagaru
H-Index: 32
COMBAT: A study of 64Cu-SAR-BBN and 67Cu-SAR-BBN for identification and treatment of GRPr-expressing metastatic castrate-resistant prostate cancer.
2024/2/1
SABRE: Assessment of safety and efficacy of 64Cu-SAR-BBN in patients with PSMA-negative biochemical recurrent prostate cancer.
2024/2/1
Real world outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with lutetium-177-PSMA-vipivotide tetraxetan (Lu177-PVT).
2024/2/1
Assessing the clinical utility of rapid post-therapy whole-body digital SPECT/CT in evaluating early treatment response of 177Lu-PSMA-617 treatment.
2024/2/1
Total and anatomically contextualized quantitative 18F-DCFPyL PET at biochemical recurrence to predict subsequent biochemical progression-free survival in …
2024/2/1
Reply to Perera Molligoda Arachchige AS [1]
2024/2
Andrei Iagaru
H-Index: 32
Spatial transcriptomic analysis drives PET imaging of tight junction protein expression in pancreatic cancer theranostics
bioRxiv
2024
James Wang
H-Index: 8
Jai Woong Seo
H-Index: 19
Martin Schneider
H-Index: 27
Bo Wu
H-Index: 4
Andrei Iagaru
H-Index: 32
European Association of Nuclear Medicine Focus 5: consensus on molecular imaging and theranostics in prostate cancer
European Urology
2024/1/1
Prospective Comparison of 68Ga-NeoB and 68Ga-PSMA-R2 PET/MRI in Patients with Biochemically Recurrent Prostate Cancer
Journal of Nuclear Medicine
2024/4/25
Heying Duan
H-Index: 10
Hong Song
H-Index: 17
Farshad Moradi
H-Index: 15
Shreyas Vasanawala
H-Index: 38
Andrei Iagaru
H-Index: 32
Alpha-emitter Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors.
2024/4/23
Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management: Preclinical and Clinical Developments of the Past 5 Years
2024/4/20
Heying Duan
H-Index: 10
Andrei Iagaru
H-Index: 32
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu] Lu-PSMA-617 in metastatic castration-resistant …
European Journal of Nuclear Medicine and Molecular Imaging
2024/4/18
